FURX

Furiex Pharmaceuticals Announces First Quarter 2013 Earnings Release and Conference Call

[at noodls] – MORRISVILLE, N.C. (April 9, 2013) – Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) will release its first quarter 2013 financial results on Tuesday, May 7, 2013, after the market closes. The earnings news … moreView todays social media effects on FURXView the latest stocks trending across Twitter. Click to view dashboardSee who Furiex is hiring next, click here to […]

Furiex Reports Fourth Quarter and Full Year 2012 Financial Results

[at noodls] – Fourth Quarter 2012 Highlights: Royalty revenues of $9.2 million, an increase of $3.6 million (65%) from third quarter 2012. Cash and cash equivalents balance of $25.7 million as of December 31, 2012. … moreView todays social media effects on FURXView the latest stocks trending across Twitter. Click to view dashboardSee who Furiex is hiring next, click here […]

Furiex Receives Qualified Infectious Disease Product and Fast Track Designations from the U.S. Food and Drug Administration for Avarofloxacin (JNJ-Q2)

[at noodls] – MORRISVILLE, N.C. (February 25, 2013) – Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) announced today that avarofloxacin (USAN adopted, INN approval pending), has been granted Qualified Infectious Disease … moreView todays social media effects on FURXView the latest stocks trending across Twitter. Click to view dashboardSee who Furiex is hiring next, click here to view […]

Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2012 Earnings Release and Conference Call

[at noodls] – Morrisville, N.C. (January 29, 2013) – Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) will release its fourth quarter and full year 2012 financial results on Wednesday, March 6, 2013, after the market closes. … moreView todays social media effects on FURXView the latest stocks trending across Twitter. Click to view dashboardSee who Furiex is hiring next, click here to […]

Furiex Reports Third Quarter 2012 Financial Results

[at noodls] – Third Quarter 2012 Highlights: Milestone revenue of $10.0 million related to Priligy® regulatory milestones. Royalty revenue of $5.6 million, an increase of $2.5 million (81.4%) from second quarter 2012. … moreView todays social media effects on FURXView the latest stocks trending across Twitter. Click to view dashboard […]

Furiex Pharmaceuticals Announces Third Quarter 2012 Earnings Release and Conference Call

[at noodls] – MORRISVILLE, N.C. (October 1, 2012) – Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) will release its third quarter 2012 financial results on Thursday, November 1, 2012, after the market closes. The earnings … moreView todays social media effects on FURXView the latest stocks trending across Twitter. Click to view dashboard […]